Otamixaban ( INN) is an experimental injectable

anticoagulant Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where the ...

direct factor Xa inhibitor that was investigated for the treatment for

acute coronary syndrome Acute coronary syndrome (ACS) is a syndrome (a set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is centrally loca ...

. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial.

References

Direct Xa inhibitors {{blood-drug-stub